Herold, Kevan C. http://orcid.org/0000-0003-1534-6613
Delong, Thomas
Perdigoto, Ana Luisa
Biru, Noah http://orcid.org/0000-0003-1891-3660
Brusko, Todd M.
Walker, Lucy S. K. http://orcid.org/0000-0001-5986-5015
Article History
Accepted: 15 December 2023
First Online: 2 February 2024
Competing interests
: K.C.H. is a co-inventor on a patent for the use of teplizumab to delay type 1 diabetes and has consulted for Sanofi, Provention Bio, GSK, Abata, Gentibio and Idorsia. He is on the scientific advisory board for Sonoma and NexImmune.